NTS-Polyplex: a potential nanocarrier for neurotrophic therapy of Parkinson's disease
dc.contributor.author | Martinez-Fong, Daniel | |
dc.contributor.author | Bannon, Michael J. | |
dc.contributor.author | Trudeau, Louis-Eric | |
dc.contributor.author | Gonzalez-Barrios, Juan A. | |
dc.contributor.author | Arango-Rodriguez, Martha L. | |
dc.contributor.author | Hernandez-Chan, Nancy G. | |
dc.contributor.author | Reyes-Corona, David | |
dc.contributor.author | Armendáriz-Borunda, Juan | |
dc.contributor.author | Navarro-Quiroga, Ivan | |
dc.date.accessioned | 2021-10-04T17:42:12Z | |
dc.date.available | 2021-10-04T17:42:12Z | |
dc.date.issued | 2012 | |
dc.description.abstract | Nanomedicine has focused on targeted neurotrophic gene delivery to the brain as a strategy to stop and reverse neurodegeneration in Parkinson's disease. Because of improved transfection ability, synthetic nanocarriers have become candidates for neurotrophic therapy. Neurotensin (NTS)-polyplex is a “Trojan horse” synthetic nanocarrier system that enters dopaminergic neurons through NTS receptor internalization to deliver a genetic cargo. The success of preclinical studies with different neurotrophic genes supports the possibility of using NTS-polyplex in nanomedicine. In this review, we describe the mechanism of NTS-polyplex transfection. We discuss the concept that an effective neurotrophic therapy requires a simultaneous effect on the axon terminals and soma of the remaining dopaminergic neurons. We also discuss the future of this strategy for the treatment of Parkinson's disease. | es |
dc.identifier.citation | Nanomedicine: Nanotechnology, Biology, and Medicine , 2012, 8: 1052–1069 | es |
dc.identifier.uri | http://dx.doi.org/10.1016/j.nano.2012.02.009 | es |
dc.identifier.uri | http://hdl.handle.net/11447/4785 | |
dc.language.iso | en | es |
dc.subject | Neurorestoration | es |
dc.subject | Neuroprotection | es |
dc.subject | Neurodegeneration | es |
dc.subject | Regeneration | es |
dc.subject | Survival | es |
dc.title | NTS-Polyplex: a potential nanocarrier for neurotrophic therapy of Parkinson's disease | es |
dc.type | Article | es |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- NTS-Polyplex a potential nanocarrier for neurotrophic therapy of Parkinson's disease.pdf
- Size:
- 2.2 MB
- Format:
- Adobe Portable Document Format
- Description:
- Texto completo
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: